2-(Chloromethyl)-3-(trifluoromethyl)pyridine, 98%, 100mg

(R)-4-Methyl-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide, 97%, 250mg

2-Chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine hydrochloride, 95.0%, 250mg

1-Ethyl-1-methyl-4-oxopiperidin-1-ium iodide, 95.0%, 1g

Sodium hypochlorite solution, 5-10% Cl, techn., 10 l, plastic packaging.

(S)-tert-Butyl 2-(6-(benzyloxy)-2-(tert-butoxycarbonylamino)hexyloxy)acetate, 95%, 1g

2,2-dimethyl-1-(3-methyl-2-thienyl)cyclopropanecarboxylic acid, 95.0%, 250mg

3-AMINO-4-CHLOROBENZENESULFONYL FLUORIDE, 95%, 250mg

5-Oxa-8-azaspiro[3.5]nonan-7-one, 95%, 500mg

(2S,3R,E)-2-Aminooctadec-4-ene-1,3-diol hydrochloride, 97%, 250mg

(4-Bromo-benzothiazol-2-yl)-carbamic acid tert-butyl ester, 95%, 500mg

1-(4-Chlorophenyl)-5-methyl-1h-pyrazole-3-carboxylic acid, 95+%, 100mg

Piperidine-3-carboxylic acid (2-hydroxy-ethyl)-amide, 97.0%, 1g